Segall Bryant & Hamill’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Buy |
476,295
+7,640
| +2% | +$207K | 0.18% | 185 |
|
|
2025
Q1 | $13.9M | Buy |
468,655
+34,781
| +8% | +$1.03M | 0.21% | 144 |
|
|
2024
Q4 | $17.2M | Sell |
433,874
-10,425
| -2% | -$413K | 0.24% | 130 |
|
|
2024
Q3 | $15.1M | Buy |
444,299
+71,086
| +19% | +$2.42M | 0.21% | 152 |
|
|
2024
Q2 | $8.09M | Buy |
373,213
+49,287
| +15% | +$1.07M | 0.14% | 218 |
|
|
2024
Q1 | $7.18M | Buy |
323,926
+51,092
| +19% | +$1.13M | 0.13% | 231 |
|
|
2023
Q4 | $7.51M | Buy |
272,834
+53,408
| +24% | +$1.47M | 0.14% | 225 |
|
|
2023
Q3 | $4.9M | Sell |
219,426
-37,455
| -15% | -$836K | 0.06% | 325 |
|
|
2023
Q2 | $6.54M | Buy |
256,881
+2,034
| +0.8% | +$51.8K | 0.07% | 300 |
|
|
2023
Q1 | $5.68M | Sell |
254,847
-8,305
| -3% | -$185K | 0.06% | 319 |
|
|
2022
Q4 | $6.24M | Sell |
263,152
-30,933
| -11% | -$734K | 0.07% | 287 |
|
|
2022
Q3 | $4.88M | Buy |
294,085
+29,324
| +11% | +$487K | 0.06% | 312 |
|
|
2022
Q2 | $5.27M | Buy |
264,761
+17,406
| +7% | +$347K | 0.06% | 304 |
|
|
2022
Q1 | $6.82M | Buy |
247,355
+68,985
| +39% | +$1.9M | 0.07% | 266 |
|
|
2021
Q4 | $7.35M | Buy |
178,370
+46,549
| +35% | +$1.92M | 0.07% | 245 |
|
|
2021
Q3 | $6.12M | Buy |
131,821
+14,984
| +13% | +$696K | 0.06% | 288 |
|
|
2021
Q2 | $4.67M | Buy |
116,837
+46,909
| +67% | +$1.88M | 0.05% | 342 |
|
|
2021
Q1 | $3.76M | Buy |
+69,928
| New | +$3.76M | 0.04% | 384 |
|